360 related articles for article (PubMed ID: 14523084)
1. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex.
González-Maeso J; Yuen T; Ebersole BJ; Wurmbach E; Lira A; Zhou M; Weisstaub N; Hen R; Gingrich JA; Sealfon SC
J Neurosci; 2003 Oct; 23(26):8836-43. PubMed ID: 14523084
[TBL] [Abstract][Full Text] [Related]
2. Hallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in senescence-accelerated mice.
Niimi K; Takahashi E; Itakura C
Exp Anim; 2010; 59(4):441-7. PubMed ID: 20660990
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.
Moreno JL; Holloway T; Albizu L; Sealfon SC; González-Maeso J
Neurosci Lett; 2011 Apr; 493(3):76-9. PubMed ID: 21276828
[TBL] [Abstract][Full Text] [Related]
4. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
5. Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.
Karaki S; Becamel C; Murat S; Mannoury la Cour C; Millan MJ; Prézeau L; Bockaert J; Marin P; Vandermoere F
Mol Cell Proteomics; 2014 May; 13(5):1273-85. PubMed ID: 24637012
[TBL] [Abstract][Full Text] [Related]
6. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.
González-Maeso J; Weisstaub NV; Zhou M; Chan P; Ivic L; Ang R; Lira A; Bradley-Moore M; Ge Y; Zhou Q; Sealfon SC; Gingrich JA
Neuron; 2007 Feb; 53(3):439-52. PubMed ID: 17270739
[TBL] [Abstract][Full Text] [Related]
7. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
[TBL] [Abstract][Full Text] [Related]
8. G
Liu X; Zhu H; Gao H; Tian X; Tan B; Su R
Biochem Biophys Res Commun; 2022 Apr; 598():20-25. PubMed ID: 35149433
[TBL] [Abstract][Full Text] [Related]
9. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions.
White FJ
Pharmacol Biochem Behav; 1986 Feb; 24(2):365-79. PubMed ID: 3952127
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.
Moreno JL; Holloway T; Rayannavar V; Sealfon SC; González-Maeso J
Neurosci Lett; 2013 Mar; 536():69-73. PubMed ID: 23333599
[TBL] [Abstract][Full Text] [Related]
12. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo.
Schmid CL; Raehal KM; Bohn LM
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):1079-84. PubMed ID: 18195357
[TBL] [Abstract][Full Text] [Related]
13. Agonist-trafficking and hallucinogens.
González-Maeso J; Sealfon SC
Curr Med Chem; 2009; 16(8):1017-27. PubMed ID: 19275609
[TBL] [Abstract][Full Text] [Related]
14. Structure-based discovery of nonhallucinogenic psychedelic analogs.
Cao D; Yu J; Wang H; Luo Z; Liu X; He L; Qi J; Fan L; Tang L; Chen Z; Li J; Cheng J; Wang S
Science; 2022 Jan; 375(6579):403-411. PubMed ID: 35084960
[TBL] [Abstract][Full Text] [Related]
15. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
[TBL] [Abstract][Full Text] [Related]
16. D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOI.
Santini MA; Balu DT; Puhl MD; Hill-Smith TE; Berg AR; Lucki I; Mikkelsen JD; Coyle JT
Behav Brain Res; 2014 Feb; 259():242-6. PubMed ID: 24269270
[TBL] [Abstract][Full Text] [Related]
17. Differential signaling signatures evoked by DOI versus lisuride stimulation of the 5-HT
Banerjee AA; Vaidya VA
Biochem Biophys Res Commun; 2020 Oct; 531(4):609-614. PubMed ID: 32814630
[TBL] [Abstract][Full Text] [Related]
18. Differences across sexes on head-twitch behavior and 5-HT
Jaster AM; Younkin J; Cuddy T; de la Fuente Revenga M; Poklis JL; Dozmorov MG; González-Maeso J
Neurosci Lett; 2022 Sep; 788():136836. PubMed ID: 35963476
[TBL] [Abstract][Full Text] [Related]
19. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
Arvanov VL; Liang X; Russo A; Wang RY
Eur J Neurosci; 1999 Sep; 11(9):3064-72. PubMed ID: 10510170
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists.
Marcher-Rørsted E; Halberstadt AL; Klein AK; Chatha M; Jademyr S; Jensen AA; Kristensen JL
ACS Chem Neurosci; 2020 May; 11(9):1238-1244. PubMed ID: 32212672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]